MiR-206 decreases brain-derived neurotrophic factor levels in a transgenic mouse model of Alzheimer's disease

Neuroscience Bulletin

Volumn 30, Issue 2, 2014, Pages 191-197

  Tian, Ning ^a   Cao, Zeyuan ^c   Zhang, Yan ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Peking University   (China)

^c RENMIN UNIVERSITY OF CHINA   (China)

Author keywords

Alzheimer's disease; APP PS1; brain derived neurotrophic factor; cell death; miR 206

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; MICRORNA; MICRORNA 206; PRESENILIN 1; UNCLASSIFIED DRUG; MIRN206 MICRORNA, MOUSE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CEREBROSPINAL FLUID; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HIPPOCAMPUS; MOUSE; NERVE CELL; NEUROPROTECTION; NEWBORN; NONHUMAN; PATHOGENESIS; PATHOLOGY; PLASMA; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ANIMAL; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MICE; MICE, TRANSGENIC; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84899968131     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-013-1419-7     Document Type: Article

References (50)

1. Price DL, Sisodia SS, Gandy SE. Amyloid beta amyloidosis in Alzheimer's disease. Curr Opin Neurol 1995, 8: 268-274.
2. Chan AW, Kocerha J. The path to microRNA therapeutics in psychiatric and neurodegenerative disorders. Front Genet 2012, 3: 82.
3. Delay C, Mandemakers W, Hebert SS. MicroRNAs in Alzheimer's disease. Neurobiol Dis 2012, 46: 285-290.
4. Delay C, Hebert SS. MicroRNAs and Alzheimer's disease mouse models: Current insights and future research avenues. Int J Alzheimers Dis 2011, 2011: 894938.
5. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294: 853-858. (Pubitemid 33032103)
6. Jin P, Zarnescu DC, Ceman S, Nakamoto M, Mowrey J, Jongens TA, et al. Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway. Nat Neurosci 2004, 7: 113-117. (Pubitemid 38129786)
7. Ashraf SI, McLoon AL, Sclarsic SM, Kunes S. Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila. Cell 2006, 124: 191-205. (Pubitemid 43069319)
8. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008, 452: 896-899. (Pubitemid 351550859)
9. Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q, et al. Striatal microRNA controls cocaine intake through CREB signalling. Nature 2010, 466: 197-202.
10. Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Mol Cell 2007, 26: 611-623. (Pubitemid 46856239)
11. Eulalio A, Huntzinger E, Nishihara T, Rehwinkel J, Fauser M, Izaurralde E. Deadenylation is a widespread effect of miRNA regulation. RNA 2009, 15: 21-32.
12. Meister G. miRNAs get an early start on translational silencing. Cell 2007, 131: 25-28. (Pubitemid 47498539)
13. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008, 455: 64-71.
14. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455: 58-63.
15. Diniz BS, Teixeira AL. Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromolecular Med 2011, 13: 217-222.
16. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 2008, 59: 201-220.
17. Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 2003, 4: 299-309. (Pubitemid 37271375)
18. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006, 361: 1545-1564. (Pubitemid 44450210)
19. Arancibia S, Silhol M, Mouliere F, Meffre J, Hollinger I, Maurice T, et al. Protective effect of BDNF against betaamyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol Dis 2008, 31: 316-326.
20. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, et al. Neuroprotective effects of brainderived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 2009, 15: 331-337.
21. Poon WW, Blurton-Jones M, Tu CH, Feinberg LM, Chabrier MA, Harris JW, et al. beta-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiol Aging 2011, 32: 821-833.
22. Peng S, Garzon DJ, Marchese M, Klein W, Ginsberg SD, Francis BM, et al. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci 2009, 29: 9321-9329.
23. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 2001, 6: 83-86. (Pubitemid 32096070)
24. Tsai SJ, Hong CJ, Liu HC, Liu TY, Hsu LE, Lin CH. Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology 2004, 49: 10-12. (Pubitemid 38134861)
25. Tsai SJ, Hong CJ, Liu HC, Liu TY, Liou YJ. The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population. Dement Geriatr Cogn Disord 2006, 21: 139-143.
26. Olin D, MacMurray J, Comings DE. Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism. Neurosci Lett 2005, 381: 275-278. (Pubitemid 40719171)
27. Cui J, Wang Y, Dong Q, Wu S, Xiao X, Hu J, et al. Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70. J Neurosci 2011, 31: 16227-16240.
28. Wang Y, Cui J, Sun X, Zhang Y. Tunneling-nanotube development in astrocytes depends on p53 activation. Cell Death Differ 2011, 18: 732-742.
29. Zhang Y, Champagne N, Beitel LK, Goodyer CG, Trifiro M, LeBlanc A. Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70. J Neurosci 2004, 24: 5315-5321. (Pubitemid 38747672)
30. Zhang Y, McLaughlin R, Goodyer C, LeBlanc A. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol 2002, 156: 519-529. (Pubitemid 34839899)
31. Cui J, Chen Q, Yue X, Jiang X, Gao GF, Yu LC, et al. Galanin protects against intracellular amyloid toxicity in human primary neurons. J Alzheimers Dis 2010, 19: 529-544.
32. Zhang Y, Hong Y, Bounhar Y, Blacker M, Roucou X, Tounekti O, et al. p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity. J Neurosci 2003, 23: 7385-7394. (Pubitemid 36999530)
33. Zhang Y, Goodyer C, LeBlanc A. Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. J Neurosci 2000, 20: 8384-8389.
34. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic - ischemic brain damage. Ann Neurol 1986, 19: 105-111. (Pubitemid 16114163)
35. Ji Y, Lu Y, Yang F, Shen W, Tang TT, Feng L, et al. Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons. Nat Neurosci 2010, 13: 302-309.
36. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 2011, 14: 347-353.
37. Lee ST, Chu K, Jung KH, Kim JH, Huh JY, Yoon H, et al. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model. Ann Neurol 2012, 72: 269 -277.
38. Chen TJ, Wang DC, Chen SS. Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons. J Neurosci Res 2009, 87: 2297-2307.
39. Echeverria V, Berman DE, Arancio O. Oligomers of beta-amyloid peptide inhibit BDNF-induced arc expression in cultured cortical Neurons. Curr Alzheimer Res 2007, 4: 518-521. (Pubitemid 350248384)
40. Wang DC, Chen SS, Lee YC, Chen TJ. Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons. Neurosci Lett 2006, 398: 78-82.
41. Bramham CR, Worley PF, Moore MJ, Guzowski JF. The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J Neurosci 2008, 28: 11760-11767.
42. Forlenza OV, Diniz BS, Talib LL, Mendonca VA, Ojopi EB, Gattaz WF, et al. Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2009, 28: 507-512.
43. Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonca VA, Gattaz WF, et al. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 2010, 22: 1305-1311.
44. Mrak RE. Neuropathology and the neuroinflammation idea. J Alzheimers Dis 2009, 18: 473-481.
45. Swerdlow RH, Burns JM, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis 2010, 20 Suppl 2: S265-279.
46. Shruster A, Melamed E, Offen D. Neurogenesis in the aged and neurodegenerative brain. Apoptosis 2010, 15: 1415-1421.
47. Chen Q, Nakajima A, Choi SH, Xiong X, Sisodia SS, Tang YP. Adult neurogenesis is functionally associated with AD-like neurodegeneration. Neurobiol Dis 2008, 29: 316-326.
48. Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry 2011, 198: 351-356.
49. Forlenza OV, Torres CA, Talib LL, de Paula VJ, Joaquim HP, Diniz BS, et al. Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease. J Psychiatr Res 2011, 45: 220-224.
50. Hooper C, Killick R, Lovestone S. The GSK3 hypothesis of Alzheimer's disease. J Neurochem 2008, 104: 1433-1439. (Pubitemid 351316776)